Globus Medical, Inc. (gmed)

GMED — Company Overview

Globus Medical, Inc. (GMED) is a mid-cap company in the Healthcare sector, operating in Medical Devices.

GMED — Business Description

Globus Medical, Inc. (GMED) operates in Medical Devices within the broader Healthcare market. Globus Medical, Inc. develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products comprising traditional fusion implants, such as pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices; treatment options for motion preservation technologies consisting of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and biologic solutions, such as allografts and synthetic alternatives. It also provides orthopedic trauma solutions, including limb reconstruction, fracture plating…

Official website: https://www.globusmedical.com.

GMED — Investment Thesis

The investment thesis for Globus Medical, Inc. (GMED) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.

• Revenue is expanding at roughly 5.9% year-over-year (public data).
• Trailing P/E of 19.21× sits in a moderate band relative to high-growth peers.
• Forward P/E (13.70×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $9.93B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

GMED — Financial Health

Financial health for Globus Medical, Inc. (GMED) is summarized from publicly reported profitability, leverage, and cash-flow metrics.

Profit margin of 17.0% indicates solid bottom-line conversion. Positive free cash flow of $554.19M supports balance-sheet flexibility.

GMED — Growth Outlook

Growth outlook for Globus Medical, Inc. (GMED) depends on demand trends in Medical Devices and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 5.9% suggests steady but measured expansion.
• Earnings declined -26.2% year-over-year — margin or volume pressure may be in play.
• Price is 27.1% below the 52-week high.

GMED — Competitive Position

Globus Medical, Inc. (GMED) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Devices.
• Market capitalization of $9.93B places GMED among mid-cap peers.
• Gross margin near 69.0% may reflect pricing power or favorable mix.

GMED — Summary

Globus Medical, Inc. (GMED) is a mid-cap Healthcare company focused on Medical Devices, listed on NYQ. Last price $73.96 with market cap $9.93B. Trailing P/E 19.21×. Revenue grew 5.9% year-over-year per public data. Notable strengths include revenue growth of 5.9% year-over-year. Key watch items include earnings decline of -26.2% year-over-year. Public estimates and earnings snapshots for Globus Medical, Inc. are on this site; ownership, live news, and deeper models remain in Vest Terminal.